ArticleGastroenterology2012

Dead on arrival: understanding the failure of CTLA4-immunoglobulin therapy in inflammatory bowel disease.

Lloyd Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.